These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27998907)

  • 1. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.
    Ridiandries A; Tan JT; Ravindran D; Williams H; Medbury HJ; Lindsay L; Hawkins C; Prosser HC; Bursill CA
    FASEB J; 2017 Mar; 31(3):1179-1192. PubMed ID: 27998907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-spectrum chemokine inhibition blocks inflammation-induced angiogenesis, but preserves ischemia-driven angiogenesis.
    Ravindran D; Cartland SP; Bursill CA; Kavurma MM
    FASEB J; 2019 Dec; 33(12):13423-13434. PubMed ID: 31574232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional regulation of angiogenesis by high-density lipoproteins.
    Prosser HC; Tan JT; Dunn LL; Patel S; Vanags LZ; Bao S; Ng MK; Bursill CA
    Cardiovasc Res; 2014 Jan; 101(1):145-54. PubMed ID: 24130189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad-Spectrum Inhibition of the CC-Chemokine Class Improves Wound Healing and Wound Angiogenesis.
    Ridiandries A; Bursill C; Tan J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite angiogenic outcome of curcumin against ischemia and Lewis lung cancer models: in silico, in vitro and in vivo studies.
    Fan S; Xu Y; Li X; Tie L; Pan Y; Li X
    Biochim Biophys Acta; 2014 Sep; 1842(9):1742-54. PubMed ID: 24970744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral-mediated delivery of a viral chemokine binding protein blocks CC-chemokine activity in vitro and in vivo.
    Bursill CA; Cai S; Channon KM; Greaves DR
    Immunobiology; 2003; 207(3):187-96. PubMed ID: 12777060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
    Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
    Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
    Forooghian F; Das B
    Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
    Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation.
    Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J
    Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of CC-Chemokines in the Regulation of Angiogenesis.
    Ridiandries A; Tan JT; Bursill CA
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
    Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
    Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-bound CC chemokine inhibitor 35K provides localized inhibition of CC chemokine activity in vitro and in vivo.
    Bursill CA; Cash JL; Channon KM; Greaves DR
    J Immunol; 2006 Oct; 177(8):5567-73. PubMed ID: 17015744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
    Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aloe-emodin suppresses hypoxia-induced retinal angiogenesis
    Wu J; Ke X; Wang W; Zhang H; Ma N; Fu W; Zhao M; Gao X; Hao X; Zhang Z
    Int J Biol Sci; 2016; 12(11):1363-1371. PubMed ID: 27877088
    [No Abstract]   [Full Text] [Related]  

  • 18. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha.
    Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY
    Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed mutagenesis of the CC chemokine binding protein 35K-Fc reveals residues essential for activity and mutations that increase the potency of CC chemokine blockade.
    White GE; McNeill E; Christou I; Channon KM; Greaves DR
    Mol Pharmacol; 2011 Aug; 80(2):328-36. PubMed ID: 21586597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.